Showing 121 - 140 results of 4,741 for search '(( decrease host resistance ) OR ( ((decrease therapeutic) OR (targeted therapeutics)) options ))', query time: 0.66s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125

    Study design. by Dita Gudra (4439767)

    Published 2023
    Subjects:
  6. 126

    Data_Sheet_1_Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Systematic Review.docx by Alaka Sahoo (10951611)

    Published 2021
    “…It covers the AMP composition, pathways and mechanisms of action, the formation of biofilms, impact of biofilms on human diseases, current strategies as well as therapeutic options to combat biofilm with antimicrobial peptides from insects. …”
  7. 127
  8. 128

    Presentation_1_Classification of expert-level therapeutic decisions for degenerative cervical myelopathy using ensemble machine learning algorithms.pdf by Dougho Park (9566450)

    Published 2022
    “…</p>Conclusion<p>ML-based classification of DCM therapeutic options is valid and feasible. This study can be a basis for establishing generalizable ML-based surgical decision models for DCM. …”
  9. 129

    Examination of CD302 as a potential therapeutic target for acute myeloid leukemia by Tsun-Ho Lo (6689747)

    Published 2019
    “…These studies provide the foundation for examining CD302 as a potential therapeutic target for AML.</p></div>…”
  10. 130
  11. 131
  12. 132
  13. 133

    Image1_Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells.tif by Damla Uludağ (12588412)

    Published 2022
    “…<p>Change in the energy metabolism of cancer cells, which display significant differences compared to normal cells, is a rising phenomenon in developing new therapeutic approaches against cancers. One of the metabolic enzymes, hexokinase-II (HK-II) is involved in glycolysis, and inhibiting the HK-II activity may be a potential metabolic target for cancer therapy as most of the drugs in clinical use act on DNA damage. …”
  14. 134
  15. 135
  16. 136

    Image_3_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF by Raimunde Liang (5418758)

    Published 2020
    “…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”
  17. 137

    Image_2_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF by Raimunde Liang (5418758)

    Published 2020
    “…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”
  18. 138

    Image_5_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF by Raimunde Liang (5418758)

    Published 2020
    “…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”
  19. 139

    Image_1_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF by Raimunde Liang (5418758)

    Published 2020
    “…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”
  20. 140

    Image_4_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF by Raimunde Liang (5418758)

    Published 2020
    “…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”